EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Microbiome–Immune Interaction in Pulmonary Arterial Hypertension: What Have We Missed?

Xin Zhou iD, Wen Tian, Shenbiao Gu, Marlene Rabinovitch, Mark R Nicolls, Michael P Snyder iD

Research · 2025-01 · 8

DOI: 10.34133/research.0669 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Research, online erschienen am 09.04.2025. Verfasst von Xin Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NHLBI NIH HHS, NIH.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary arterial hypertension (PAH) is a devastating disease characterized by perivascular inflammation, immune dysregulation, and vascular remodeling. Recent studies have unveiled a potential link between the gut microbiome and PAH pathogenesis, suggesting that microbial dysbiosis and increased intestinal permeability may contribute to the inflammatory pathology in PAH and ultimately disease progression. This perspective highlights the emerging evidence of the role of leaky gut in PAH, the interplay between microbiota-induced immune responses, and the activation of endogenous retroviruses like human endogenous retrovirus K. Understanding these complex interactions opens new interdisciplinary avenues for research and therapeutic interventions, potentially transforming PAH management through microbiome-targeted strategies.

Autor:innen und Institutionen

  • Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.
  • Division of Pulmonary, Allergy, and Critical Care Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  • Veteran Affairs Palo Alto Health Care System, Palo Alto, CA, USA.
  • Basic Science and Engineering (BASE) Initiative at the Betty Irene Moore Children's Heart Center, Lucile Packard Children's Hospital, Stanford University School of Medicine, Stanford, CA, USA.
  • Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA.

ORCID-Profile: Xin Zhou, Michael P Snyder

Förderung

  • BLRD VA
  • NHLBI NIH HHS
  • NIH

Zitieren

APA

Zhou, X., Tian, W., Gu, S., Rabinovitch, M., Nicolls, M. R., & Snyder, M. P. (2025). Microbiome–Immune Interaction in Pulmonary Arterial Hypertension: What Have We Missed?. Research, 8. https://doi.org/10.34133/research.0669

Vancouver

Zhou X, Tian W, Gu S, Rabinovitch M, Nicolls MR, Snyder MP. Microbiome–Immune Interaction in Pulmonary Arterial Hypertension: What Have We Missed?. Research. 2025;8. doi:10.34133/research.0669

BibTeX
@article{Zhou2025,
  author = {Zhou, Xin and Tian, Wen and Gu, Shenbiao and Rabinovitch, Marlene and Nicolls, Mark R and Snyder, Michael P},
  title = {Microbiome–Immune Interaction in Pulmonary Arterial Hypertension: What Have We Missed?},
  journal = {Research},
  year = {2025},
  volume = {8},
  doi = {10.34133/research.0669}
}
Kostenlos starten →